Header Logo

Connection

SARAH WHITTLE to Neovascularization, Pathologic

Back to Details
This is a "connection" page, showing publications SARAH WHITTLE has written about Neovascularization, Pathologic.
SARAH WHITTLE
Connection Strength
0.484
Neovascularization, Pathologic
  1. The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692.
    View in: PubMed
    Score: 0.484
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.